Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
MET-097i is a next-generation ultra-long-acting GLP-1 agonist designed to enable once-monthly dosing, potentially transforming treatment adherence and convenience
Riboflavin plays a key role in energy production, which is essential for healthy fat metabolism, while Bromelain is known for its ability to break down proteins and fats, potentially aiding in the fat dissolving process
Its sequence ( GEPPPGKPADDAGLV ) and physicochemical profile make it useful for exploring cell migration, survival, angiogenesis pathways, and tissue biology in vitro
Caution: Must be taken with adequate water
Clinical trials have demonstrated that certain GLP-1 receptor agonists reduce the risk of major adverse cardiovascular events in patients with type 2 diabetes and established cardiovascular disease
US$ 26.05
US$ 27.59
US$ 25.73
US$ 24.26
US$ 21.68
US$ 22.20
